ArticleCancer science2023

Gemcitabine plus nab-paclitaxel for pancreatic cancer and interstitial lung disease: A nationwide longitudinal study.

Kei Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.